SEC 13F Intelligence

Point72 Europe (London) LLP / BIIB

Point72 Europe (London) LLP’s Biogen Inc Position

Does Point72 Europe (London) LLP own Biogen Inc (BIIB)? Yes99.0K shares worth $14M (+0.68% of its 13F portfolio) as of Q3 2025, up from 95.7K shares the prior filed quarter.

Position Value
$14M
Q3 2025
Shares
99.0K
% of Portfolio
+0.68%
Quarters Held
3
currently held

Position History BIIB

Reported value by quarter
Q1 ’25: $11MQ1 ’25Q2 ’25: $12MQ2 ’25Q3 ’25: $14MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202599.0K$14M+0.68%
Q2 202595.7K$12M+0.46%
Q1 202582.5K$11M+0.77%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Point72 Europe (London) LLP’s full portfolio or all institutional holders of BIIB.